Jenny Metz 
Medicaid cuts significantly reduce access to vital mental health and addiction services, placing some of the most vulnerable individuals at heightened risk for untreated illness, relapse, and overdose. Many people with substance use disorders and serious mental health conditions rely on Medicaid for medications, therapy, inpatient and outpatient treatment, and recovery supports. When funding is … Read more
Sexual misconduct in addiction treatment facilities is a serious issue that targets vulnerable individuals in recovery. Patients may face trauma, power imbalances, and emotional instability, increasing their risk. Prevention relies on self-management strategies like boundary-setting, strong family advocacy and communication, and community resources such as oversight agencies and reporting systems. These combined efforts help ensure … Read more
Patient safety in addiction treatment relies on strong standards and support systems. Government policies enforce safe practices, while individuals contribute through self-management and informed care. Families offer supervision and advocacy, and communities provide certified programs, education, and peer support. Together, these efforts create a safer, more effective path to recovery. Patient Safety Standards in Addiction … Read more
Short-form video addiction involves excessive use of quick, engaging videos that stimulate dopamine release and reinforce addictive brain pathways. Preventing and managing this addiction includes self-care, like setting limits and mindful watching, family support through clear boundaries and healthy role modeling, and community resources such as education and counseling to encourage balanced technology use. Hooked … Read more
Self-care is essential in addiction recovery, helping individuals heal physically and emotionally, build resilience, and maintain stability. While it supports long-term recovery, challenges like avoidance, false security, and unequal access can arise. Ethical issues include balancing autonomy with the need for support and respecting privacy. Families support recovery by modeling healthy habits and offering practical … Read more
Non-alcoholic drinks may seem safe for people in recovery, but they can trigger relapse by mimicking alcohol’s taste, look, and rituals. They’re often used to fit in socially, manage cravings, or test control, yet even small alcohol traces or familiar cues can reactivate addiction pathways. A solid relapse prevention plan should set clear boundaries, provide … Read more
A deflection program for addiction redirects people from the criminal justice system to treatment and support services. It offers benefits like reducing incarceration and promoting recovery, but faces challenges such as limited access, possible coercion, and ethical concerns around autonomy and privacy. Success depends on combining medical treatment with self-management, family involvement, and strong community … Read more
Drug withdrawal happens when someone dependent on a substance stops or reduces use, causing the brain’s chemistry—especially dopamine, GABA, and norepinephrine pathways—to become unbalanced. This leads to physical symptoms like nausea and muscle pain, and emotional symptoms such as anxiety and cravings. Treatment often includes medical detox, medication-assisted therapy, and behavioral support. Success is improved … Read more
Adderall addiction develops when a medication prescribed for ADHD is misused to enhance focus, energy, or academic and work performance, leading to repeated dopamine surges in the brain’s reward pathways. These artificial increases in dopamine reinforce compulsive use, gradually increasing tolerance and creating both psychological and physical dependence. What may begin as occasional misuse can … Read more
Tideglusib, a GSK-3β inhibitor initially developed for neurodegenerative diseases, is now being explored as a treatment for alcohol use disorder (AUD). Early research suggests it may reduce chronic alcohol intake by targeting brain pathways linked to addiction. Potential advantages include reduced relapse risk and non-daily dosing. However, disadvantages include limited human trial data and possible … Read more